Methods and compositions for the treatment of gastrointestinal disorders
CA 2529307 C · Owner: Ironwood Pharmaceuticals, Inc. · Inventors: Mahajan-Miklos, Shalina; Li, Jing Sun; Currie, Mark G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g. gastrointestinal motility disorders functional gastrointestinal disorders, gastroesophageal reflux disease (GERD) duodenogastric reflux, Crohn's disease ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudoobstruction), and disorders and conditions associated with constipation, e.g. constipation associated with use of opiate pain killers post-surgical constipation, and constipation associated with neuropathic disorders as well …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 14, 2004 and granted December 24, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 14, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 14, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.